Enter at least 4 characters

1 results showing for: 'rotavirus oral vaccine'

Rotavirus oral vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 315.
- Only on a prescription
- No patient co-payment payable
  • Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube
    • Brand Fully subsidised brand. Rotarix
    • Pharmacode2650290
    • Subsidy $0.00
    • Measure / Qty per 10
  • Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator
    • Brand Fully subsidised brand. Rotarix
    • Pharmacode2509415
    • Subsidy $0.00
    • Measure / Qty per 10
    Rotarix to be Principal Supply on 1 December 2024
  1. Maximum of two doses for people meeting the following:

    1. first dose to be administered in infants aged under 14 weeks of age; and

    2. no vaccination being administered to children aged 24 weeks or over.

  2. Contractors will be entitled to claim payment from the Funder for the supply of Rotavirus oral vaccine to people eligible under the above criteria pursuant to their contract with Health New Zealand (Health NZ) for subsidised immunisation, and they may only do so in respect of the Rotavirus oral vaccine listed in the Pharmaceutical Schedule.

  3. Contractors may only claim for populations within the criteria that are covered by their contract, which may be a sub-set of the population described in paragraph A above.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply